Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
HIV Infections
About this trial
This is an interventional prevention trial for HIV Infections focused on measuring Drug Therapy, Combination, Ampicillin, Nevirapine, Disease Transmission, Vertical, Anti-Infective Agents, Erythromycin, Reverse Transcriptase Inhibitors, Metronidazole, Anti-HIV Agents, Chorioamnionitis, HIV Seronegativity
Eligibility Criteria
Inclusion Criteria HIV positive. 20 to 24 weeks pregnant. Willing to take the planned antibiotic treatment. Planning to deliver at 1 of the study sites. Willing to come back for follow-up visits for 1 year after the baby is born. Exclusion Criteria Have taken antibiotics, except for syphilis or gonorrhea, within the last 2 weeks. Are allergic to penicillin, ampicillin, erythromycin, or metronidazole. Have major illnesses, such as diabetes, severe kidney or heart disease, or active tuberculosis, which might affect the pregnancy. Are having major problems with the pregnancy, such as placenta previa, ruptured membranes, or multiple pregnancy. Have a central nervous system disease, such as seizures. Are taking anticoagulant drugs.
Sites / Locations
- Megan Valentine